Global and regional burden of ischemic stroke disease from 1990 to 2021: an age-period cohort analysis

Weimin Zhu, Xiaxia He, Daochao Huang, Yiqing Jiang, Weijun Hong, Shaofa Ke, En Wang, Feng Wang, Xianwei Wang, Renfei Shan, Suzhi Liu, Yinghe Xu, Yongpo JiangmedRxiv 2024 · DOI

TL;DR

While global age-standardized rates of ischemic stroke (IS) have declined over the last three decades, the absolute number of cases and deaths is surging due to aging populations. This study warns that by 2035, the burden will intensify significantly for individuals over 45, driven primarily by persistent risk factors like hypertension and rising blood glucose levels.

What Problem Does This Paper Address?

Ischemic stroke—caused by blood vessel obstruction—accounts for over 60% of all stroke cases globally. While medical interventions like thrombolysis and thrombectomy have advanced, the global health system faces a "silver tsunami": as people live longer, the total number of strokes increases even if the risk for any single individual (at a specific age) is lower than it used to be.

The authors identify a gap in existing literature regarding long-term, age-stratified predictions. Most studies look at broad trends but fail to disentangle the complex interplay between biological aging, period-specific medical advancements, and "cohort effects" (how the era you were born in influences your lifetime risk). This paper aims to provide a granular roadmap for public health policy through 2035.

Methods

The researchers employed a sophisticated statistical toolkit to analyze longitudinal health data:

  • Joinpoint Regression: Used to identify specific "inflection points" in time where the trends in stroke rates significantly changed.
  • Age-Period-Cohort (APC) Modeling: A crucial epidemiological tool that separates the effects of Age (biological risk), Period (impact of new technologies or global events), and Cohort (lifestyle/environmental factors unique to a birth year).
  • Bayesian Age-Period-Cohort (BAPC): Used for forecasting. This method is generally considered more robust than traditional APC models for predicting future disease burdens because it better accounts for uncertainty and prior knowledge.
  • Socio-Demographic Index (SDI): A summary measure of a geography's socio-economic development used to categorize regions and identify disparities.

Datasets

The primary data source was the Global Burden of Disease (GBD) Study 2021. This is a massive, standardized database managed by the Institute for Health Metrics and Evaluation (IHME) that evaluates health loss across 204 countries. The study specifically extracted:

  • Incidence, mortality, and Disability-Adjusted Life Years (DALYs).
  • Data on 87 risk factors.
  • Estimates from the Global Health Data Exchange (GHDx).

Key Insights and Ideas

  • The Aging Paradox: Between 1990 and 2021, the rate of stroke (adjusted for age) fell. However, the absolute number of cases rose by 88% and deaths by 55%. We are winning the battle against the disease on a per-capita basis but losing the war against the sheer volume of patients.
  • Regional Extremes: East Asia bears the highest absolute burden (most cases), but Eastern Europe has the highest age-standardized incidence. Conversely, high-income Asia-Pacific regions (like Japan and South Korea) saw the most dramatic declines in burden, likely due to superior hypertension management and early intervention.
  • The "Middle-Age" Shift: Projections for 2035 show a worrying trend: while stroke outcomes are improving for those under 35, they are projected to worsen for everyone over 45. The 50-59 age group is specifically flagged for a potential rise in incidence rates.
  • Hypertension is King: Despite decades of public health campaigns, hypertension remains the most significant and stable driver of stroke mortality. While environmental pollution and LDL cholesterol impacts have fluctuated, high blood glucose is a rapidly growing concern.

Key Results

  • 2021 Snapshot: 7.8 million global IS patients, 3.6 million deaths, and 70.4 million DALYs.
  • Historical Trends (1990–2021):
    • Age-standardized incidence rate: -0.578% annually.
  • Age-standardized mortality: -0.927% annually.
  • Age-standardized DALYs: -14.372% (total decrease).
  • SDI Correlation: High SDI regions have significantly lower indicators across the board, suggesting that economic development and healthcare infrastructure are the strongest shields against stroke burden.

Limitations and Future Work

The authors acknowledge several constraints:

  • Data Quality: GBD data relies on the reporting accuracy of individual countries, which can be inconsistent or biased in lower-income regions.
  • Missing Variables: The analysis does not account for genetic factors or specific environmental nuances beyond broad categories like "pollution."
  • Scope: The study focuses on ischemic stroke; it does not address hemorrhagic stroke, which may have different risk profiles and trends.

Future Work: The authors call for more research into "personalized interventions" and suggest that public health policies must pivot from general awareness to targeted management of hypertension and cholesterol in populations aged 45 and older.

Summary updated

Abstract

Abstract Background Ischemic stroke is a major global public health concern. This study evaluates the burden of ischemic stroke in 2021, analyzes trends since 1990, and predicts future burdens. Methods Data were sourced from the Global Burden of Disease Study 2021, focusing on incidence, mortality, and disability-adjusted life years (DALYs) on a global, regional, and all socio-demographic index area (SDI) basis. Joinpoint regression and age-period-cohort modeling were employed for trend analysis. Results In 2021, there were 7,804,449 (95% UI, 6,719,760 - 8,943,692) global ischemic stroke patients, resulting in 3,591,499 (95% UI, 3,213,281 - 3,888,327) deaths and 70,357,912 (95% UI, 64,329,576 - 76,007,063) DALYs. East Asia had the highest number of cases, while Eastern Europe had the highest age-standardized incidence rate. High-income countries reported the lowest rates of incidence, mortality, and DALYs, which are significantly declining overall. From 1990 to 2021, the age-standardized incidence rate decreased by -0.578% annually, mortality by -0.927%, and DALYs by -14.372%. The rates are influenced by age, time, and cohorts, generally increasing with age but declining over time, especially in high SDI regions. Key risk factors include hypertension, environmental pollution, and high low density lipoprotein cholesterol, with hypertension having the most significant and stable impact. Projections for 2035 suggest worsening ischemic stroke outcomes for those over 45, while improvements are expected for individuals under 35. The 50-59 age group’s age-standardized incidence rate may rise, but mortality and DALYs rates are expected to decline across all ages. Conclusion Our study shows a decline in ischemic stroke mortality and incidence, yet its global burden is rising due to aging populations and persistent health issues. This highlights the importance of targeting prevention and treatment, particularly for those over 45. Future efforts must tackle high rates in affected areas and address key risks like hypertension and high cholesterol.
BibTeX
@misc{zhu2024global,
  author = {Weimin Zhu and Xiaxia He and Daochao Huang and Yiqing Jiang and Weijun Hong and Shaofa Ke and En Wang and Feng Wang and Xianwei Wang and Renfei Shan and Suzhi Liu and Yinghe Xu and Yongpo Jiang and Yongpo Jiang and Yongpo Jiang},
  title = {{Global and regional burden of ischemic stroke disease from 1990 to 2021: an age-period cohort analysis}},
  year = {2024},
  doi = {10.1101/2024.08.29.24312683},
  howpublished = {medRxiv},
}
Figure